Novartis Ag NVS
NYSE NVS
$137.50 -0.20 (-0.15%)
As of: Sep 9, 2026 · 3:59 PM EDT

Novartis Ag (NVS) EPS (Basic) (2009 - 2026)

Novartis Ag's (NVS) quarterly EPS (Basic) came in at $1.68 in Q2 2026, down 15.94% year-over-year from $2.0 in Q2 2025, and down 27.82% quarter-over-quarter from $2.33 in Q1 2026.

Analysis

Novartis Ag (NVS) EPS (Basic) (2009 - 2026) Analysis & Trends

Novartis Ag has disclosed EPS (Basic) across 18 years of filings, most recently posting $1.68 for Q2 2026.

  • In Q2 2026, EPS (Basic) fell 15.94% year-over-year to $1.68; the TTM figure through Jun 2026 stood at $11.6 (down 4.15% YoY), while the FY2025 annual figure was $7.21, up 21.88% from the prior year.
  • EPS (Basic) came in at $1.68 for Q2 2026 at Novartis Ag, down from $2.33 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $6.45 in Q4 2023 to a low of $0.76 in Q2 2022.
  • Average EPS (Basic) over 5 years is $2.4, with a median of $1.72 recorded in 2024.
  • Year-over-year, EPS (Basic) sank 58.54% in 2022 and surged 94.73% in 2024.
  • Over 5 years, EPS (Basic) stood at $3.32 in 2022, then soared by 94.43% to $6.45 in 2023, then decreased by 10.97% to $5.74 in 2024, then retreated by 8.03% to $5.28 in 2025, then slumped by 68.13% to $1.68 in 2026.
  • Per Business Quant data, the three most recent EPS (Basic) figures were $1.68 in Q2 2026, $2.33 in Q1 2026, and $5.28 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Johnson & Johnson 643.26 Bn 622.50 Bn 17.26 Bn 2.30
2 AbbVie 443.31 Bn 436.74 Bn 12.70 Bn 2.04
3 Merck 364.74 Bn 357.60 Bn 12.21 Bn -0.54
4 Novartis Ag 266.46 Bn 258.77 Bn 11.24 Bn 1.68
5 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -0.04
6 Sanofi 52.33 Bn 44.95 Bn 10.79 Bn 0.33
7 Revolution Medicines 43.79 Bn 43.79 Bn - -3.06
8 Incyte 25.23 Bn 20.69 Bn 1.57 Bn 2.92
9 United Therapeutics 21.67 Bn 19.01 Bn 683.80 Mn 7.82
10 Neurocrine Biosciences 15.65 Bn 15.26 Bn 935.80 Mn 1.43
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.68
Mar 31, 2026 2.33
Dec 31, 2025 5.28
Sep 30, 2025 2.21
Jun 30, 2025 2.00
Mar 31, 2025 2.58
Dec 31, 2024 5.74
Sep 30, 2024 1.73
Jun 30, 2024 1.56
Mar 31, 2024 1.72
Dec 31, 2023 6.45
Sep 30, 2023 0.89
Jun 30, 2023 1.12
Mar 31, 2023 1.46
Dec 31, 2022 3.32
Sep 30, 2022 0.93
Jun 30, 2022 0.76
Mar 31, 2022 1.39
Dec 31, 2021 8.00
Sep 30, 2021 1.63